NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
54 trialsNCT06270706 2024-06-12
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Phase 1 Unknown
NCT06075849 2024-02-23
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Phase 1 Unknown
NCT04224480 2024-01-19
Longitudinal Immune-phenotyping of HCC Following MK-3475
National Cancer Centre, Singapore
Phase 1 Unknown
NCT06144385 2024-01-02
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 1 Unknown
NCT05031949 2023-12-19
CCGLC-003
Tongji Hospital
Phase 1 Unknown
NCT05533892 2023-12-19
CCGLC-007
Tongji Hospital
Phase 1 Unknown
NCT06088459 2023-10-18
NWRD06 DNA Plasmid for HCC After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT06065592 2023-10-06
CAT_PB
Lebanese University
Phase 1 Unknown
NCT05352646 2023-09-28
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT05675462 2023-03-06
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Fudan University
Phase 1 Unknown
NCT05536427 2023-03-02
Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma
Peking Union Medical College Hospital
Phase 1 Unknown
NCT05738447 2023-02-22
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
West China Hospital
Phase 1 Unknown
NCT05225116 2023-02-08
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT04612504 2023-02-02
SynOV1.1 Intratumoral Injection Study
Beijing Syngentech Co., Ltd.
Phase 1 Unknown
NCT00986661 2022-11-02
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT05059821 2022-08-11
PROVE
Ain Shams University
Phase 1 Unknown
NCT05339321 2022-05-10
Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC
Peking Union Medical College Hospital
Phase 1 Unknown
NCT05363722 2022-05-06
A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT04564313 2022-05-03
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT05353894 2022-04-29
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
Genoscience Pharma
Phase 1 Unknown
NCT05281926 2022-03-16
A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients
National Taiwan University Hospital
Phase 1 Unknown
NCT05131763 2021-11-23
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Fudan University
Phase 1 Unknown
NCT04121273 2021-03-03
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Unknown
NCT04665362 2021-01-22
IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT04677088 2020-12-21
TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation
First Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT04550663 2020-09-23
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Unknown
NCT03507998 2020-07-24
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Curegenix Inc.
Phase 1 Unknown
NCT03734926 2020-07-22
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04104074 2020-07-07
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT04368182 2020-04-29
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Zhejiang University
Phase 1 Unknown
NCT03971747 2020-04-07
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.
Phase 1 Unknown
NCT03583125 2019-09-11
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
Phase 1 Unknown
NCT04032392 2019-07-25
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Beijing 302 Hospital
Phase 1 Unknown
NCT03966209 2019-05-31
Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT03899415 2019-04-10
TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
Beijing 302 Hospital
Phase 1 Unknown
NCT03908840 2019-04-09
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Evolve Biologics
Phase 1 Unknown
NCT03793322 2019-01-04
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
Zhujiang Hospital
Phase 1 Unknown
NCT02719782 2018-11-16
A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation
Lion TCR Pte. Ltd.
Phase 1 Unknown
NCT03674073 2018-10-18
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
Chinese PLA General Hospital
Phase 1 Unknown
NCT02293850 2018-08-20
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Oncolys BioPharma Inc
Phase 1 Unknown
NCT03175705 2018-01-18
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC
Beijing YouAn Hospital
Phase 1 Unknown
NCT03235167 2017-09-18
Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy
Dalian University
Phase 1 Unknown
NCT02882659 2016-08-30
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
FullHope Biomedical Co., Ltd.
Phase 1 Unknown
NCT02399735 2016-07-21
Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT02423239 2016-04-06
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
e-Therapeutics PLC
Phase 1 Unknown
NCT02586285 2016-04-01
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 1 Unknown
NCT02587884 2016-03-31
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
Eastern Hepatobiliary Surgery Hospital
Phase 1 Unknown
NCT02403544 2016-01-05
Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
ChineseAMS
Phase 1 Unknown
NCT01914263 2015-04-16
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
Alliancells-PuRui Biocience Co., Ltd.
Phase 1 Unknown